Key Tuberculosis Diagnostics Market Trend 2024-2033: Growth and Forecast Analysis

Don't miss out on The Business Research Company's Early Year-End Sale! For a limited time only, you can get up to 30% off our detailed market research reports!

The global tuberculosis diagnostics market experienced robust growth in recent years and is on the threshold of notable expansion during the next few years. According to data from the Tuberculosis Diagnostics Global Market Report 2024, the market size is projected to grow from $2.11 billion in 2023 to $2.27 billion in 2024, reflecting a Compound Annual Growth Rate CAGR of 7.7%. The growth observed in the historic period stems from the rise in the incidence of tuberculosis, an escalation in healthcare expenditure, the proliferation of healthcare facilities, and the increased adoption of nucleic acid testing.

Preview the extensive range of insights projected by this report with the Sample Link: https://www.thebusinessresearchcompany.com/sample.aspx?id=8165&type=smp

Notably, the tuberculosis diagnostics market is anticipated to witness a strong growth trajectory in the following years, with expectations to swell to a hefty $3.02 billion in 2028 at a CAGR of 7.4%. Factors fueling growth during the forecast period include robust government support, an uptick in FDA approvals for tuberculosis diagnostics, a surge in research and development R&D activities, and the emergence of drug-resistant tuberculosis strains. Emerging trends in the forecast period encompass a focus on next-generation sequencing NGS platforms for tuberculosis diagnostics, product innovations, T-cell tests for tuberculosis infection, AI-based tuberculosis diagnostics, the use of portable devices, and collaborations between governments and manufacturers.

The report further explores the range of key market drivers, with increasing incidence of tuberculosis holding the primary position. Tuberculosis is a severe infectious disease predominantly affecting the lungs that can have debilitating consequences. The disease spreads through coughing and sneezing, releasing minuscule germs into the surrounding air. Tuberculosis diagnostics play a vital role in patient detection, helping facilitate earlier diagnosis and detection of related diseases.

In March 2022, the US-based national public health agency, Centers for Disease Control and Prevention, released a weekly report documenting a 9.4% rise in tuberculosis infections in the United States during 2021. A total of 7,860 tuberculosis cases were reported in 2021, reflecting an increase from 7,173 cases in 2020. Hence, the rise in the incidence of tuberculosis has been propelling the growth of the tuberculosis diagnostics market.

Preserve the health of your business intelligence with the full report: https://www.thebusinessresearchcompany.com/report/tuberculosis-diagnostics-global-market-report

Major companies operating in the tuberculosis diagnostics market include Beckton, Dickinson and Company, F. Hoffmann-La Roche Ltd, Qiagen N.V, BioMerieux SA, Danaher Corporation, PerkinElmer, Thermo Fisher Scientific Inc., Creative Diagnostics, Lionex GmbH, Biocartis, and others. These industry giants have been ramping up their game by unveiling technological innovations, such as advanced Point-of-Care POC diagnostic methods that operate on AI technology.

For instance, in August 2022, Fujifilm, a Japan-based corporation developing medical imaging devices, forged a partnership with Qure.ai, a US-based AI-enabled medical imaging solution provider. Together, they launched an advanced POC diagnostic technique leveraging a battery-operated X-ray machine for tuberculosis detection. AI algorithms in this method maximize testing efficiency, offering ultra-portability, high precision, and optimal POC diagnostic solutions.

The report richly details the segmentation of the tuberculosis diagnostics market as follows:
1 By Test Type: Radiographic Tests, Nucleic Acid Testing, Cytokine Detection Tests, Drug Resistance Tests, Skin Test/Mantoux Test TST, Blood/Serology Test, Smear Microscopy Tests, Cell Culture-Based Tests, Other Test Types.
2 By Disease Stage: Latent Tuberculosis, Active Tuberculosis
3 By End-User: Hospitals And Diagnostic Laboratories, Physician's Office Laboratories, Reference Laboratories, Academics And Research Facilities

In 2023, Asia-Pacific dominated the global tuberculosis diagnostics market, outpacing other regions. The regions covered in the report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ "

Glean a wealth of insights about The Business Research Company. Having published over 15000+ reports across 27 industries in 60+ geographies, the company houses extensive secondary research, 1,500,000 datasets, and gathers exclusive insights from interviews with industry leaders.

This release was published on openPR.